Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: A pilot study

T. Y. Chuang, D. A. Lewis, Dan Spandau

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: In order to prevent the propagation of genetic mutations, human keratinocytes irradiated with ultraviolet (UV) B light in vitro undergo premature stress-induced senescence or apoptosis. This response to UVB irradiation is dependent on the functional activation of the insulin-like growth factor-1 receptor (IGF-1R). Based on this in vitro functional data, we hypothesized that the increased serum levels of insulin in patients with type 2 diabetes may activate the IGF-1R in skin and lead to a decreased frequency of skin cancer in these patients. Objectives: To determine whether the use of insulin by patients with type 2 diabetes correlated with a change in the incidence in nonmelanoma skin cancer (NMSC). Methods: A historical cohort study identifying the incidence of NMSC following the use of two different pharmacological therapies. The patient population was restricted to caucasians who were at least 50 years old when they began the indicated pharmacological therapy. The first group consisted of 1440 patients who used insulin therapy to treat type 2 diabetes and the second group comprised 4135 patients who used cimetidine to treat their gastrointestinal ailments. An additional group of 6131 patients with diabetes who used noninsulin antidiabetics was added to examine the effect of noninsulin therapies. All patients had regular follow-up visits at the Regenstrief Clinics during the study period between 1980 and 1999. The Regenstrief Clinics is an outpatient facility which serves the general population in Metro-Indianapolis, Indiana, U.S.A. Results: The incidence of NMSC in patients using insulin was significantly lower than in patients using cimetidine (1.25% vs. 2.35%, P < 0.2). The decrease in NMSC in patients with type 2 diabetes correlated specifically with the use of insulin (NMSC incidence insulin-only patients with diabetes: 1-40% vs. those with diabetes using noninsulin therapies: 2-35%, P = 0.11). Conclusions: Patients using exogenous insulin had a lower risk of developing NMSC and the protective effect of insulin use becomes more distinct with increasing age.

Original languageEnglish
Pages (from-to)552-557
Number of pages6
JournalBritish Journal of Dermatology
Volume153
Issue number3
DOIs
StatePublished - Sep 2005

Fingerprint

Skin Neoplasms
Type 2 Diabetes Mellitus
Insulin
Incidence
Somatomedin Receptors
Cimetidine
Pharmacology
Therapeutics
Medical Genetics
Ultraviolet Rays
Ambulatory Care Facilities
Type 1 Diabetes Mellitus
Keratinocytes
Hypoglycemic Agents
Population
Cohort Studies

Keywords

  • Ageing
  • Incidence
  • Insulin
  • Insulin-like growth factor-1 receptor
  • Skin cancer

ASJC Scopus subject areas

  • Dermatology

Cite this

Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin : A pilot study. / Chuang, T. Y.; Lewis, D. A.; Spandau, Dan.

In: British Journal of Dermatology, Vol. 153, No. 3, 09.2005, p. 552-557.

Research output: Contribution to journalArticle

@article{7a58270924754e98963d83867bf554b1,
title = "Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: A pilot study",
abstract = "Background: In order to prevent the propagation of genetic mutations, human keratinocytes irradiated with ultraviolet (UV) B light in vitro undergo premature stress-induced senescence or apoptosis. This response to UVB irradiation is dependent on the functional activation of the insulin-like growth factor-1 receptor (IGF-1R). Based on this in vitro functional data, we hypothesized that the increased serum levels of insulin in patients with type 2 diabetes may activate the IGF-1R in skin and lead to a decreased frequency of skin cancer in these patients. Objectives: To determine whether the use of insulin by patients with type 2 diabetes correlated with a change in the incidence in nonmelanoma skin cancer (NMSC). Methods: A historical cohort study identifying the incidence of NMSC following the use of two different pharmacological therapies. The patient population was restricted to caucasians who were at least 50 years old when they began the indicated pharmacological therapy. The first group consisted of 1440 patients who used insulin therapy to treat type 2 diabetes and the second group comprised 4135 patients who used cimetidine to treat their gastrointestinal ailments. An additional group of 6131 patients with diabetes who used noninsulin antidiabetics was added to examine the effect of noninsulin therapies. All patients had regular follow-up visits at the Regenstrief Clinics during the study period between 1980 and 1999. The Regenstrief Clinics is an outpatient facility which serves the general population in Metro-Indianapolis, Indiana, U.S.A. Results: The incidence of NMSC in patients using insulin was significantly lower than in patients using cimetidine (1.25{\%} vs. 2.35{\%}, P < 0.2). The decrease in NMSC in patients with type 2 diabetes correlated specifically with the use of insulin (NMSC incidence insulin-only patients with diabetes: 1-40{\%} vs. those with diabetes using noninsulin therapies: 2-35{\%}, P = 0.11). Conclusions: Patients using exogenous insulin had a lower risk of developing NMSC and the protective effect of insulin use becomes more distinct with increasing age.",
keywords = "Ageing, Incidence, Insulin, Insulin-like growth factor-1 receptor, Skin cancer",
author = "Chuang, {T. Y.} and Lewis, {D. A.} and Dan Spandau",
year = "2005",
month = "9",
doi = "10.1111/j.1365-2133.2005.06738.x",
language = "English",
volume = "153",
pages = "552--557",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin

T2 - A pilot study

AU - Chuang, T. Y.

AU - Lewis, D. A.

AU - Spandau, Dan

PY - 2005/9

Y1 - 2005/9

N2 - Background: In order to prevent the propagation of genetic mutations, human keratinocytes irradiated with ultraviolet (UV) B light in vitro undergo premature stress-induced senescence or apoptosis. This response to UVB irradiation is dependent on the functional activation of the insulin-like growth factor-1 receptor (IGF-1R). Based on this in vitro functional data, we hypothesized that the increased serum levels of insulin in patients with type 2 diabetes may activate the IGF-1R in skin and lead to a decreased frequency of skin cancer in these patients. Objectives: To determine whether the use of insulin by patients with type 2 diabetes correlated with a change in the incidence in nonmelanoma skin cancer (NMSC). Methods: A historical cohort study identifying the incidence of NMSC following the use of two different pharmacological therapies. The patient population was restricted to caucasians who were at least 50 years old when they began the indicated pharmacological therapy. The first group consisted of 1440 patients who used insulin therapy to treat type 2 diabetes and the second group comprised 4135 patients who used cimetidine to treat their gastrointestinal ailments. An additional group of 6131 patients with diabetes who used noninsulin antidiabetics was added to examine the effect of noninsulin therapies. All patients had regular follow-up visits at the Regenstrief Clinics during the study period between 1980 and 1999. The Regenstrief Clinics is an outpatient facility which serves the general population in Metro-Indianapolis, Indiana, U.S.A. Results: The incidence of NMSC in patients using insulin was significantly lower than in patients using cimetidine (1.25% vs. 2.35%, P < 0.2). The decrease in NMSC in patients with type 2 diabetes correlated specifically with the use of insulin (NMSC incidence insulin-only patients with diabetes: 1-40% vs. those with diabetes using noninsulin therapies: 2-35%, P = 0.11). Conclusions: Patients using exogenous insulin had a lower risk of developing NMSC and the protective effect of insulin use becomes more distinct with increasing age.

AB - Background: In order to prevent the propagation of genetic mutations, human keratinocytes irradiated with ultraviolet (UV) B light in vitro undergo premature stress-induced senescence or apoptosis. This response to UVB irradiation is dependent on the functional activation of the insulin-like growth factor-1 receptor (IGF-1R). Based on this in vitro functional data, we hypothesized that the increased serum levels of insulin in patients with type 2 diabetes may activate the IGF-1R in skin and lead to a decreased frequency of skin cancer in these patients. Objectives: To determine whether the use of insulin by patients with type 2 diabetes correlated with a change in the incidence in nonmelanoma skin cancer (NMSC). Methods: A historical cohort study identifying the incidence of NMSC following the use of two different pharmacological therapies. The patient population was restricted to caucasians who were at least 50 years old when they began the indicated pharmacological therapy. The first group consisted of 1440 patients who used insulin therapy to treat type 2 diabetes and the second group comprised 4135 patients who used cimetidine to treat their gastrointestinal ailments. An additional group of 6131 patients with diabetes who used noninsulin antidiabetics was added to examine the effect of noninsulin therapies. All patients had regular follow-up visits at the Regenstrief Clinics during the study period between 1980 and 1999. The Regenstrief Clinics is an outpatient facility which serves the general population in Metro-Indianapolis, Indiana, U.S.A. Results: The incidence of NMSC in patients using insulin was significantly lower than in patients using cimetidine (1.25% vs. 2.35%, P < 0.2). The decrease in NMSC in patients with type 2 diabetes correlated specifically with the use of insulin (NMSC incidence insulin-only patients with diabetes: 1-40% vs. those with diabetes using noninsulin therapies: 2-35%, P = 0.11). Conclusions: Patients using exogenous insulin had a lower risk of developing NMSC and the protective effect of insulin use becomes more distinct with increasing age.

KW - Ageing

KW - Incidence

KW - Insulin

KW - Insulin-like growth factor-1 receptor

KW - Skin cancer

UR - http://www.scopus.com/inward/record.url?scp=24344463518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24344463518&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2133.2005.06738.x

DO - 10.1111/j.1365-2133.2005.06738.x

M3 - Article

C2 - 16120142

AN - SCOPUS:24344463518

VL - 153

SP - 552

EP - 557

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 3

ER -